PT1129709E - Composicao farmaceutica a base de ibuprofeno e um procedimento para a sua preparacao - Google Patents

Composicao farmaceutica a base de ibuprofeno e um procedimento para a sua preparacao

Info

Publication number
PT1129709E
PT1129709E PT01500053T PT01500053T PT1129709E PT 1129709 E PT1129709 E PT 1129709E PT 01500053 T PT01500053 T PT 01500053T PT 01500053 T PT01500053 T PT 01500053T PT 1129709 E PT1129709 E PT 1129709E
Authority
PT
Portugal
Prior art keywords
ibuprofen
preparation
pharmaceutical composition
composition based
mixing
Prior art date
Application number
PT01500053T
Other languages
English (en)
Inventor
Perez Maria Teresa Tarre
Faus Xavier Font
Casas Montserrat Trullols
Original Assignee
Aplicaciones Farmacodinamicas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farmacodinamicas filed Critical Aplicaciones Farmacodinamicas
Publication of PT1129709E publication Critical patent/PT1129709E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT01500053T 2000-03-03 2001-03-01 Composicao farmaceutica a base de ibuprofeno e um procedimento para a sua preparacao PT1129709E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000522A ES2171110B1 (es) 2000-03-03 2000-03-03 Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Publications (1)

Publication Number Publication Date
PT1129709E true PT1129709E (pt) 2005-10-31

Family

ID=8492565

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01500053T PT1129709E (pt) 2000-03-03 2001-03-01 Composicao farmaceutica a base de ibuprofeno e um procedimento para a sua preparacao

Country Status (8)

Country Link
EP (1) EP1129709B1 (pt)
AT (1) ATE298567T1 (pt)
CZ (1) CZ301553B6 (pt)
DE (1) DE60111657T2 (pt)
DK (1) DK1129709T3 (pt)
ES (1) ES2171110B1 (pt)
PT (1) PT1129709E (pt)
SK (1) SK285338B6 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
EP1942877A4 (en) * 2005-11-02 2011-09-14 Teikoku Pharma Usa Inc ORGANOLEPTICALLY ACCEPTABLE ORAL DOSAGE FORMS OF IBUPROFEN, MANUFACTURING METHOD AND APPLICATION
EP1840188B1 (en) 2006-03-31 2011-09-07 Sony Deutschland GmbH A composition comprising at least one type of liquid crystal
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
EP1974751A1 (en) * 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
CN102448499A (zh) * 2009-04-27 2012-05-09 药效学应用实验室股份有限公司 赖氨酸布洛芬口服混悬剂
EP2253329B1 (en) 2009-04-27 2016-09-21 Laboratorio de Aplicaciones Farmacodinamicas, S.A. Ibuprofen lysinate oral suspension
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
ES2171110B1 (es) 2003-06-16
SK285338B6 (sk) 2006-11-03
CZ2001714A3 (cs) 2001-10-17
EP1129709B1 (en) 2005-06-29
SK2932001A3 (en) 2001-12-03
DE60111657T2 (de) 2006-05-04
CZ301553B6 (cs) 2010-04-14
EP1129709A3 (en) 2001-11-14
EP1129709A2 (en) 2001-09-05
DK1129709T3 (da) 2005-10-24
ES2171110A1 (es) 2002-08-16
DE60111657D1 (de) 2005-08-04
ATE298567T1 (de) 2005-07-15

Similar Documents

Publication Publication Date Title
HK1096034A1 (en) A solid dosage form comprising a fibrate
DK1381432T3 (da) HSA-frie interferon-beta-præparater
DE69811233D1 (de) Feste lösungen und dispersionen von eines schlecht wasserlöslichen wirkstoffes
HK1080364A1 (en) Oral pharmaceutical forms of liquid drugs having improved bioavailability
ATE204160T1 (de) Formulierung zur inhalativen applikation
AU2001279631A1 (en) Self-emulsifying active substance formulation and use of this formulation
SE0102036D0 (sv) Pharmaceutical formulation for the efficient administration of apomorphine, 6aR- (-) -N- Propyl- norapomorphine and their derivatives and pro-drugs thereof
PT1129709E (pt) Composicao farmaceutica a base de ibuprofeno e um procedimento para a sua preparacao
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
BR9809571A (pt) Composição medicinal e processo para produzì-la
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
ATE299697T1 (de) Feste zubereitungen mit ramipril
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
NO20010537D0 (no) Farmasöytiske preparater omfattende ibuprofen og domperidon
WO2003028624A3 (en) Levothyroxine compositions and methods
BR0009334A (pt) Excipiente na forma de pó para o uso emapresentações farmacêuticas sólidas, e, processopara produzir o mesmo
HRP20000781B1 (en) Effervescent preparations
DK1312355T3 (da) Vandopløselige, ikke-brusende farmaceutiske præparater omfattende ikke-steroide antiinflammatoriske medikamenter
WO2004014318A3 (en) Levothyroxine compositions and methods
AU2369801A (en) Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation
WO2003013441A3 (en) Levothyroxine compositions and methods
EA200200211A1 (ru) Фармацевтическая композиция и ее приготовление
EA200300768A1 (ru) Фармацевтическая композиция, содержащая циталопрам